Santhera Pharmaceuticals Holding AG (0QN1)
Market Closed
15 Oct, 03:30 PM
14. 54
CHF +0.56
+4.0057%
111.21M Market Cap
- P/E Ratio
- Div Yield
3,999 Volume
-6.11 Eps
13.98 CHF
Previous Close Want to track 0QN1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Santhera Pharmaceuticals Holding AG (0QN1) Statistics
Valuation metrics
Market Cap 111.21M
Enterprise value 211.3M
Trailing P/E (ttm) -6.26
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 2.09
Price/Book (mrq) -33.2
Enterprise Value/Revenue 2.08
Enterprise Value/EBITDA -62.91
Overview
Shares outstanding 6.44M
Float 10.56M
Shares short -
% Held by insiders 0.15%
% Held by institutions 0.09%
Average volume (10 days) 3.06K
Average volume (90 days) 7.63K
Price summary
52-Week low 9.54
52-Week high 18.72
Beta -0.34
50-Day moving average 15.52
200-Day moving average 15.9
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0.1:1
Last split Date 3 Jul 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.31%
Operating margin -0.09%
Operational effectiveness
Return on assets -0.22%
Return on equity 3.55%
Income Statement
Revenue (ttm) 77.19M
Revenue per share (ttm) 7.07
Quarterly revenue growth (yoy) 1.13%
Gross profit (ttm) 15.17M
EBITDA -32.54M
Net income to common (ttm) -49.24M
Diluted EPS (ttm) -2.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 22.44M
Total cash per share (mrq) 2.91
Total debt (mrq) 48.95M
Total Debt/Equity (mrq) -6.69
Current ratio (mrq) 1.73%
Book value per share (mrq) -0.43
Cash Flow
Cash flow statement -34.76M
Levered free cash flow (LFCF) -35.63M
2026 © Marketlog. All Rights Reserved.
